Anti-phospholipid syndrome: Clinical spectrum and therapeutical/prophylactic strategies in the pediatric population

European Review for Medical and Pharmacological Sciences

Volumn 12, Issue 1, 2008, Pages 47-53

  Rigante, Donato ^a   Gaspari, S ^a   Bersani, G ^a   Stabile, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Anti phospholipid syndrome; Children

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ENOXAPARIN; HEPARIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; PHOSPHOLIPID ANTIBODY; UROKINASE; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLEEDING; BLOOD CLOTTING TEST; CHILD; CHILD HEALTH; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG INDICATION; DRUG MEGADOSE; HUMAN; PATHOLOGICAL ANATOMY; PLASMAPHERESIS; RISK FACTOR; SEROPREVALENCE; THROMBOCYTOPENIA; THROMBOSIS; VENOUS THROMBOEMBOLISM;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CARDIOLIPINS; CHILD; HUMANS; SEVERITY OF ILLNESS INDEX; THROMBOSIS;

EID: 41149098095     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. BICK RL. Anti-phospholipid thrombosis syndromes: etiology, pathophysiology, diagnosis and management. Int J Hematol 1997; 65: 193-213.
2. AMES PR. Anti-phospholipid antibodies, thrombosis and atherosclerosis in systemic lupus erythematosus: a unifying "membrane stress syndrome" hypothesis. Lupus 1994; 3: 371-377.
3. GEZER S. Antiphospholipid syndrome. Dis Mon 2003; 49: 691-742.
4. LEVY DM, MASSICOTTE MP, HARVEY E, HEBERT D, SILVERMAN ED. Thromboembolism in paediatric lupus patients. Lupus 2003; 12: 741-746.
5. WILSON WA, GHARAVI AE, KOIKE T, LOCKSHIN MD, BRANCH DW, PIETTE JC, BREY R, DERKSEN R, HARRIS EN, HUGHES GR, TRIPLETT DA, KHAMASHTA MA. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-1311.
6. VILA P, HERNANDEZ MC, LOPEZ-FERNANDEZ MF, BATLLE J. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemost 1994; 72: 209-213.
7. RAVELLI A, MARTINI A, BURGIO GR. Antiphospholipid antibodies in paediatrics. Eur J Pediatr 1994; 153: 472-479.
8. MATSUURA E, IGARASHI Y, YASUDA T, TRIPLETT DA, KOIKE T. Anti-cardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994; 179: 457-462.
9. CONSTANTIN T, PONYI A, FEKETE G. Clinical relevance of anti-phospholipid antibody tests in childhood. Eur J Pediatr 2004; 163: 507.
10. GATTORNO M, BUONCOMPAGNI A, MOLINARI AC, BARBANO GC, MORREALE G, STALLA F, PICCO P, MORI PG, PISTOIA V. Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anti-cardiolipin antibodies are at risk for clinical manifestations related to the anti phospholipid syndrome. Br J Rheumatol 1995; 34: 873-881.
11. CERVERA R, PIETTE JC, FONT J, KHAMASHTA MA, SHOENFELD Y, CAMPS MT, JACOBSEN S, LAKOS G, TINCANI A, KONTOPOULOU-GRIVA I, GALEAZZI M, MERONI PL, DERKSEN RH, DE GROOT PG, GROMNICA-IHLE E, BALEVA M, MOSCA M, BOMBARDIERI S, HOUSSIAU F, GRIS JC, QUÉRÉ I, HACHULLA E, VASCONCELOS C, ROCH B, FERNANDEZ-NEBRO A, BOFFA MC, HUGHES GR, INGELMO M; EURO-PHOSPHOLIPID PROJECT GROUP. Anti-phospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019-1027.
12. LEVINE JS, BRANCH DW, RAUCH J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-763.
13. SHERGY WJ, KREDICH DW, PISETSKY DS. The relationship of anticardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosus. J Rheumatol 1988; 15: 1389-1394.
14. FALCINI F, TACCETTI G, ERMINI M, TRAPANI S, MATUCCI CERINIC M. Catastrophic antiphospholipid antibody syndrome in pediatric sistemic lupus erythematosus. J Rheumatol 1997; 24: 389-392.
15. ERKAN D, CERVERA R, ASHERSON RA. Catastrophic anti-phospholipid syndrome. Where do we stand? Arthritis Rheum 2003; 48: 3320-3327.
16. RAVELLI A, MARTINI A. Antiphospholipid antibody sindrome in pediatric patients. Rheum Dis Clin N Am 1997; 23: 657-676.
17. GATTORNO M, FALCINI F, RAVELLI A, ZULIAN F, BUONCOMPAGNI A, MARTINI G, RESTI M, PICCO P, MARTINI A. Outcome of primary antiphospholipid syndrome in childhood. Lupus 2003; 12: 449-453.
18. ANGELINI L, RAVELU A, CAPORALI R, RUMI V, NARDOCCI N, MARTINI A. High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia. Pediatrics 1994; 94: 500-503.
19. SCHMUGGE M, REVEL-VILK S, HIRAKI L, RAND ML, BLANCHETTE VS, SILVERMAN ED. Thrombocytopenia and thromboembolism in pediatric systemic lupus erythematosus. J Pediatr 2003; 143: 666-669.
20. RAND JH. The antiphospholipid syndrome. Annu Rev Med 2003; 54: 409-424.
21. NAVARRO F, DOÑA-NARANJO MA, VILLANUEVA I. Neonatal antiphospholipid syndrome. J Rheumatol 1997; 24: 1240-1241.
22. LOCKSHIN MD, SAMMARITANO LR, SCHWARTZMAN S. Validation of the Sapporo criteria for anti phospholipid syndrome. Arthritis Rheum 2000; 43: 440-443.
23. MIYAKIS S, LOCKSHIN MD, ATSUMI T, BRANCH DW, BREY RL, CERVERA R, DERKSEN RH, DE GROOT PG, KOIKE T, MERONI PL, REBER G, SHOENFELD Y, TINCANI A, VLACHOYIANNOPOULOS PG, KRILIS SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
24. KHAMASHTA MA, CUADRADO MJ, MUJIC F, TAUB NA, HUNT BJ, HUGHES GR. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332: 993-997.
25. ALARCON-SEGOVIA D, BOFFA MC, BRANCH W, CERVERA R, CHARAVI A, KHAMASHTA M, SHOENFELD M, WILSON Y, ROUBEY R. Phophylaxis of the antiphospholipid syndrome: a consensus report. Lupus 2003; 12: 499-503.
26. CROWTHER MA, GINSBERG JS, JULIAN J, DENBURG J, HIRSH J, DOUKETIS J, LASKIN C, FORTIN P, ANDERSON D, KEARON C, CLARKE A, GEERTS W, FORGIE M, GREEN D, COSTANTINI L, YACURA W, WILSON S, GENT M, KOVACS MJ. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome. N Engl J Med 2003; 349: 1133-1138.
27. ASHERSON RA, CERVERA R, DE GROOT PG, ERKAN D, BOFFA MC, PIETTE JC, KHAMASHTA MA, SHOENFELD Y, CATASTROPHIC ANTIPHOSPHOUPID SYNDROME REGISTRY PROJECT GROUP. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 2003; 12: 503-504.
28. GIRÓN-GONZÁLEZ JA, GARCÍA DEL RÍO E, RODRÍGUEZ C, RODRÍGUEZ-MARTORELL J, SERRANO A. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. J Rheumatol 2004; 31: 1560-1567.